Sarecycline for Acne: Trial Results

The American Academy of Dermatology gives oral sarecycline a conditional recommendation for acne: suitability depends on individual circumstances. Its guidance also calls for limiting oral antibiotic use and combining antibiotics with benzoyl peroxide to reduce antibiotic resistance. Ask what else belongs in your treatment plan and when to review it.¹

Who entered?

Two double-blind trials randomized 2,002 people with moderate-to-severe facial acne, eligible ages 9–45. Treatment was daily weight-based sarecycline or placebo for 12 weeks.²

What changed?

At week 12, modeled clear/almost-clear inflammatory-acne ratings with at least a two-grade improvement were 21.9% versus 10.5% and 22.6% versus 15.3%, sarecycline versus placebo. Adjusted mean inflammatory-lesion reductions were 15.3 versus 10.1 and 15.1 versus 10.7. Both primary outcomes favored sarecycline statistically.²

12–16% lacked week-12 data; analyses estimated missing outcomes. Placebo comparisons cannot rank antibiotics. Allergan submitted trials; FDA² recorded investigator financial ties.²

What needs checking?

The US indication is inflammatory lesions of non-nodular moderate-to-severe acne, age 9+. Reassess if unimproved after 12 weeks; effectiveness beyond 12 weeks is not established.³

Pregnancy requires stopping Seysara as soon as pregnancy is recognized and contacting the prescriber. Breastfeeding is not recommended. Have a pharmacist check other medicines: oral isotretinoin and sarecycline should not be combined, and iron or antacids can impair absorption.³

Possible problems include nausea, sun sensitivity and serious antibiotic-associated diarrhea. Headache with blurred vision needs prompt medical assessment because tetracyclines can raise pressure inside the skull and threaten sight. Swallow with adequate fluid to reduce esophageal injury.³

What should I track?

At your appointment, ask which lesions the treatment targets, what improvement would justify continuing, and which adverse effects should trigger earlier contact. A review date also provides a point to discuss reducing antibiotic exposure and maintaining an appropriate topical plan.¹

“Twelve Weeks” in Skin, Head to Toe describes dated photographs in consistent light and notes on products, irritation and cycle changes. Bring those records to the agreed review; contact your clinician sooner about concerning symptoms.